Home - Products - GPCR/G Protein - Dopamine Receptor - Nomifensine (maleate)

Nomifensine (maleate)

CAS No. 32795-47-4

Nomifensine (maleate)( (±)-Nomifensine maleat )

Catalog No. M22410 CAS No. 32795-47-4

Nomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	48	In Stock
10MG	29	In Stock
25MG	43	In Stock
50MG	60	In Stock
100MG	99	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Nomifensine (maleate)
Note

Research use only, not for human use.
Brief Description

Nomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder.
Description

Nomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder.
In Vitro

——
In Vivo

——
Synonyms

(±)-Nomifensine maleat
Pathway

GPCR/G Protein
Target

Dopamine Receptor
Recptor

dopamine uptake
Research Area

——
Indication

——

Chemical Information

CAS Number

32795-47-4
Formula Weight

354.4
Molecular Formula

C20H22N2O4
Purity

>98% (HPLC)
Solubility

DMSO:80 mg/mL (225.73 mM); H2O:2.2 mg/mL (6.21 mM; Need ultrasonic)
SMILES

OC(=O)\C=C/C(O)=O.CN1CC(c2ccccc2)c2cccc(N)c2C1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Kinney J L . Nomifensine maleate: a new second-generation antidepressant.[J]. Clinical Pharmacy, 1985, 4(6):625-636.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

NGD 94-1

NGD 94-1 is a selective D4 receptor antagonist with an affinity of 3 nM for the D4 receptor and greater than 2 pM for the D1, D2, D3, and D5 receptors.
CCT241736

CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant mutants including FLT3-ITD and FLT3.
Lensiprazine

Lensiprazine (SLV314) is a potent dopamine D(2) receptor antagonist that acts as a serotonin reuptake inhibitor , and can be used to study bipolar disorder and schizophrenia.

Sign In Join Free